Contact
Email: | , |
---|---|
Phone: | +420 54949 5246 |
Research group: | Molecular Oncology - Solid Cancer - Ondřej Slabý |
Workplace: |
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2020
- Ahmad, P; Slavik, M; Trachtova, K; Gablo, NA; Kazda, T; Gurin, D; Smilek, P; Horakova, Z; Gal, B; Hermanova, M; Slampa, P; Sana, J; Slaby, O, 2020: Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients. CELLULAR ONCOLOGY 43(3), p. 505 - 511, doi: 10.1007/s13402-020-00507-7
- Vybihal, V; Smrcka, M; Roskova, I; Kazda, T; Sprlakova-Pukova, A; Sana, J; Slaby, O; Vecera, M; Kren, L; Fadrus, P, 2020: Surgical treatment of brain metastases. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE 83(2), p. 157 - 165, doi: 10.14735/amcsnn2020157
2019
- Kopkova, A; Sana, J; Machackova, T; Vecera, M; Radova, L; Trachtova, K; Vybihal, V; Smrcka, M; Kazda, T; Slaby, O; Fadrus, P, 2019: Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors. CANCERS 11(10), doi: 10.3390/cancers11101546
- Kopkova, A; Sana, J; Vecera, M; Machackova, T; Fadrus, P; Kovacova, J; Slaby, O, 2019: Global analysis and validation of miRNA levels in cerebrospinal fluid of brain tumor patients. CANCER RESEARCH 79(13), doi: 10.1158/1538-7445.AM2019-1806
- Vecera, M; Oppelt, J; Radova, L; Lipina, R; Reguli, S; Smrcka, M; Jancalek, R; Filip, M; Hermanova, M; Kren, L; Sana, J; Kopkova, A; Kovacova, J; Slaby, O, 2019: Dysregulated expression of lncRNAs in glioblastoma multiforme and their association with overall survival. CANCER RESEARCH 79(13), doi: 10.1158/1538-7445.AM2019-3575
- Vecera, M; Sana, J; Oppelt, J; Tichy, B; Alena, K; Lipina, R; Smrcka, M; Jancalek, R; Hermanova, M; Kren, L; Slaby, O, 2019: Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs. PLOS ONE 14(2), doi: 10.1371/journal.pone.0211978
- Slavik, M; Shatokhina, T; Sana, J; Ahmad, P; Kazda, T; Selingerova, I; Hermanova, M; Cervena, R; Novotny, T; Burkon, P; Smilek, P; Horakova, Z; Slampa, P; Slaby, O, 2019: Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41(4), p. 940 - 949, doi: 10.1002/hed.25533
- Ahmad, P; Sana, J; Slavik, M; Gurin, D; Radova, L; Gablo, NA; Kazda, T; Smilek, P; Horakova, Z; Gal, B; Hermanova, M; Slampa, P; Slaby, O, 2019: MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy. CANCER GENOMICS & PROTEOMICS 16(2), p. 139 - 146, doi: 10.21873/cgp.20119
- Hatina, J; Kripnerova, M; Houfkova, K; Pesta, M; Kuncova, J; Sana, J; Slaby, O; Rodriguez, R, 2019: Sarcoma Stem Cell Heterogeneity. STEM CELLS HETEROGENEITY - NOVEL CONCEPTS 1123, p. 95 - 118, doi: 10.1007/978-3-030-11096-3_7
2018
- Hermanova, M; Ahmad, P; Sana, J; Slavik, M; Shatokhina, T; Slaby, O, 2018: MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma. MODERN PATHOLOGY 31, p. 476 - 476
- Sana, J; Busek, P; Fadrus, P; Besse, A; Radova, L; Vecera, M; Reguli, S; Stollinova Sromova, L; Hilser, M; Lipina, R; Lakomy, R; Kren, L; Smrcka, M; Sedo, A; Slaby, O., 2018: Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. SCIENTIFIC REPORTS , doi: 10.1038/s41598-018-20929-6
- Kopkova, A; Sana, J; Fadrus, P; Slaby, O., 2018: Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , doi: 10.1515/cclm-2017-0958
- Slavik, M; Shatokhina, T; Sana, J; Ahmad, P; Hermanova, M; Kazda, T; Slampa, P; Slaby, O, 2018: CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.. RADIOTHERAPY AND ONCOLOGY 127, p. S1265 - S1265, doi: 10.1016/S0167-8140(18)32601-X
- Slavik, M; Ahmad, P; Sana, J; Shatokhina, T; Kazda, T; Hermanova, M; Slampa, P; Slaby, O, 2018: The Role of MicroRNAs Expression Model in Head and Neck Squamous Cell Carcinoma.. RADIOTHERAPY AND ONCOLOGY 127, p. S1264 - S1264, doi: 10.1016/S0167-8140(18)32599-4
- Vecera, M; Sana, J; Lipina, R; Smrcka, M; Slaby, O, 2018: Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19(9), doi: 10.3390/ijms19092754
- Kopkova, A; Sana, J; Fadrus, P; Machackova, T; Vecera, M; Vybihal, V; Juracek, J; Vychytilova-Faltejskova, P; Smrcka, M; Slaby, O, 2018: MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PLOS ONE 13(12), doi: 10.1371/journal.pone.0208580
- Gurin, D; Slavik, M; Hermanova, M; Shatokhina, T; Sana, J; Kazda, T; Selingerova, I; Ahmad, P; Smilek, P; Horakova, Z; Hendrych, M; Slampa, P; Slaby, O, 2018: Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. JOURNAL OF ORAL PATHOLOGY & MEDICINE 47(9), p. 864 - 872, doi: 10.1111/jop.12772
- Pospisil, P; Solar, P; Bulik, M; Burkon, P; Slampa, P; Sana, J; Slaby, O; Jancalek, R; Kazda, T, 2018: COMPARISON OF N-ACETYLASPARTATE CONCENTRATION DECREASE IN HIPPOCAMPAL AND WHITE BRAIN TISSUE AFTER WHOLE BRAIN RADIOTHERAPY. NEURO-ONCOLOGY 20, p. 306 - 306
- Jancalek, R; Solar, P; Pospisil, P; Bulik, M; Burkon, P; Hynkova, L; Slampa, P; Sana, J; Slaby, O; Kazda, T, 2018: HIPPOCAMPAL N - ACETYLASPARTATE CONCENTRATION CORRELATES TO VERBAL MEMORY BEFORE RADIOTHERAPY FOR BRAIN METASTASES. NEURO-ONCOLOGY 20, p. 306 - 307
- Kazda, T; Kuklova, A; Belanova, R; Pospisil, P; Burkon, P; Hynkova, L; Slampa, P; Sana, J; Slaby, O; Jancalek, R, 2018: LATERALITY OF HIPOCCAMPAL METASTASES: MRI ANALYSIS OF 260 PATIENTS WITH 2595 BRAIN METASTASES. NEURO-ONCOLOGY 20, p. 307 - 307
2017
- Ondracek, J; Fadrus, P; Sana, J; Besse, A; Loja, T; Vecera, M; Radova, L; Smrcka, M; Slampa, P; Slaby, O, 2017: Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. ANTICANCER RESEARCH 37(3), p. 1099 - 1104, doi: 10.21873/anticanres.11422
- Ahmad, P; Sana, J; Slavik, M; Slampa, P; Smilek, P; Slaby, O, 2017: MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. DISEASE MARKERS , doi: 10.1155/2017/8245345
- Novak, J; Sana, J; Stracina, T; Novakova, M; Slaby, O, 2017: Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria. CARDIOVASCULAR TOXICOLOGY 17(3), p. 355 - 359, doi: 10.1007/s12012-016-9393-8
2016
- Capoor, MN; Ruzicka, F; Machackova, T; Jancalek, R; Smrcka, M; Schmitz, JE; Hermanova, M; Sana, J; Michu, E; Baird, JC; Ahmed, FS; Maca, K; Lipina, R; Alamin, TF; Coscia, MF; Stonemetz, JL; Witham, T; Ehrlich, GD; Gokaslan, ZL; Mavrommatis, K; Birkenmaier, C; Fischetti, VA; Slaby, O, 2016: Prevalence of Propionibacterium acnes in Intervertebral Discs of Patients Undergoing Lumbar Microdiscectomy: A Prospective Cross-Sectional Study. PLOS ONE 11(8), doi: 10.1371/journal.pone.0161676
- Besse, A; Sana, J; Lakomy, R; Kren, L; Fadrus, P; Smrcka, M; Hermanova, M; Jancalek, R; Reguli, S; Lipina, R; Svoboda, M; Slampa, P; Slaby, O, 2016: MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. TUMOR BIOLOGY 37(6), p. 7719 - 7727, doi: 10.1007/s13277-015-4654-x
2014
- Sana, J; Radova, L; Lakomy, R; Kren, L; Fadrus, P; Smrcka, M; Besse, A; Nekvindova, J; Hermanova, M; Jancalek, R; Svoboda, M; Hajduch, M; Slampa, P; Vyzula, R; Slaby, O, 2014: Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. CARCINOGENESIS 35(12), p. 2756 - 2762, doi: 10.1093/carcin/bgu212
2011
- Svachova, H; Pour, L; Sana, J; Kovarova, L; Raja, KRM; Hajek, R, 2011: Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients. LEUKEMIA RESEARCH 35(8), p. 1008 - 1013, doi: 10.1016/j.leukres.2011.03.001
- Sana, J; Zambo, I; Skoda, J; Neradil, J; Chlapek, P; Hermanova, M; Mudry, P; Vasikova, A; Zitterbart, K; Hampl, A; Sterba, J; Veselska, R, 2011: CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines. ANALYTICAL CELLULAR PATHOLOGY 34(6), p. 303 - 318, doi: 10.3233/ACP-2011-0018
- Studium PIWI-interagujících RNA u glioblastomových kmenových buněk a jejich možné klinické implikace, Ministry of Health of the CR, 2019 - 2022
- Využití tkáňových mikroRNA pro identifikaci pacientů majících benefit z adjuvantní radioterapie po chirurgickém odstranění atypického meningeomu, Ministry of Health of the CR, 2019 - 2022
- Rozšíření současných prognostických skórovacích systémů u mozkových metastáz o mikroRNA profilování s cílem individualizace pooperační péče, Ministry of Health of the CR, 2018 - 2021
- Vývoj a validace inovativních detekčních systémů pro stanovení močových mikroRNA v diagnostice urologických nádorů, , 2019 - 2021
- Národní centrum lékařské genomiky (LM2015091), Ministerstvo školství, mládeže a tělovýchovy ČR, 2016 - 2019
- Identifikace nových prognostických markerů a terapeutických cílových molekul u sarkomu měkkých tkání (GA17-17636S), Grantová agentura ČR, 2017 - 2019
- Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
- Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Analýza mikroRNA v glioblastomových kmenových buňkách: predikce léčebné odpovědi a identifikace nových terapeutických cílů u pacientů s glioblastomem, Ministry of Health of the CR, 2012 - 2015
- Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
- Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013